mpox vaccines Stories
The funds, allocated in the 2025/26 financial year by the National Treasury, are expected to stabilise vaccine availability and support an expansive i...
The majority of cases have been reported in Busia (48 cases) and Mombasa (37), followed by Nakuru (16) and Makueni (10). Smaller clusters emerged in N...
Other counties with confirmed cases include Makueni (10), Nairobi (5), Kajiado (3), Bungoma (3), Taita Taveta (2), Kericho (2), Kilifi (2), Machakos (...
WHO pointed to mounting evidence that people living with untreated or poorly managed HIV are at significantly higher risk of developing severe complic...
Ethiopia reported its first mpox case on May 25 when a 21-day-old infant tested positive in Moyale near the Kenyan border.
These doses will primarily target the worst-affected areas, particularly focusing on at-risk populations affected by regional displacements due to sec...
Health officials have prioritised high-risk groups for vaccination, including healthcare workers, close contacts of confirmed cases, long-distance tru...
The infection often causes fever, rash and swollen lymph nodes. Last month, the Africa CDC announced that the ongoing mpox outbreak in Africa remains...
Years of mismanagement, corruption, and financial instability have left the healthcare system fragile hospitals remain underfunded, patients struggle...
Over the past decade, mpox, Marburg, and Ebola have collectively claimed tens of thousands of lives and cost billions of dollars in containment and mi...
The disease has spread across 12 counties, with cases reported in Nakuru (10), Mombasa (8), Busia (7), Nairobi (2), Kajiado (2), Bungoma (2), Taita Ta...
Screenings have been intensified at major border crossings, including Busia, Malaba, and Suam, as well as at the Jomo Kenyatta International Airport.
Before the latest violence, mpox cases had been stabilising, said WHO Director-General Tedros Adhanom Ghebreyesus, in a speech to the agency’s executi...
The vaccination programme will be rolled out in three phases, informed by epidemiological data and the risk levels of specific groups.
Testing at the national referral laboratory, which has processed 386 samples from various counties, revealed 36 positive cases.
To further strengthen its response, the government will roll out vaccination programmes in high-risk areas and enhance contact tracing efforts.
The outbreak has spread across 12 counties, prompting the government to ramp up efforts to control its spread through enhanced surveillance and robust...
Although no cases have been reported locally, health experts warn of the virus's possible entry due to global trade and movement, drawing parallels wi...
According to the latest Ministry of Health data, Kenya has recorded 31 Mpox cases. Of these, 28 patients have recovered, two remain hospitalised, and...
Efforts to educate the public on mpox prevention and control are ongoing, focusing on community engagement.
Africa's reliance on foreign aid for healthcare and preparedness continues to weaken its ability to respond effectively to health crises.
The doses' arrival will boost hopes of curbing the outbreak, which the WHO has declared a global public health emergency.
So far, the DRC has recorded 406 cases of the undiagnosed disease. Severe cases have been reported among severely malnourished people, including 31 de...
The newly reported cases include three from Nakuru County and two from Mombasa County.
A medical team has been deployed to the Panzi health zone to collect samples and carry out an analysis to know the root cause of the disease.
Twenty African countries have seen more than 59,000 reported mpox cases including 1,164 deaths so far this year, according to Africa CDC data.
Mpox is a viral infection that spreads through close contact, and typically causes flu-like symptoms and pus-filled lesions. It is usually mild, but i...
While most people recover without complications, the disease can cause severe illness in some individuals.
The cases are distributed across several counties: Nakuru (4), Nairobi (2), Mombasa (2), Kajiado (2), Bungoma (2), Taita Taveta (1), Busia (1), Makuen...
The trial, set to take place in Kenya, will focus on assessing the vaccine's safety, tolerability, and immunogenicity.
